How NEXT Life Sciences Is Redefining Contraception for Men with Plan A™

For the first time in decades, a major innovation in reproductive health is on the horizon.

In this episode of StartUp Health NOW, StartUp Health community member Dr. Darlene Walley, CEO of NEXT Life Sciences, joins Unity Stoakes to discuss Plan A™, a long-acting, non-hormonal, fully reversible male contraceptive that could reshape how couples share family planning.

Dr. Walley explains how Plan A works as a medical device, the company’s global license for Vasalgel®, and the breakthrough results from 100% successful delivery device trials across two continents. With FDA-approved development plans and growing clinical momentum, the company is on track to submit for approval by 2027.

Beyond science, this conversation explores a cultural shift: how men are stepping up to share responsibility for contraception and how this innovation could expand access, improve preventive care, and strengthen relationships worldwide.

Listen in for a look at the future of men’s health, reproductive equity, and one of the most anticipated breakthroughs in medical innovation.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.